{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:04:50Z","timestamp":1790643890956,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.autrev.2014.08.023","type":"journal-article","created":{"date-parts":[[2014,8,23]],"date-time":"2014-08-23T09:34:19Z","timestamp":1408786459000},"page":"1048-1054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study"],"prefix":"10.1016","volume":"13","author":[{"given":"Maria Giovanna","family":"Danieli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Gambini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Pettinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Logullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Gabrielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.autrev.2014.08.023_bb0005","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/cei.12194","article-title":"Diagnosis, pathogenesis and treatment of myositis: recent advances","volume":"175","author":"Carstens","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2014.08.023_bb0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaut.2013.11.005","article-title":"The clinical features, diagnosis and classification of dermatomyositis","volume":"48\u201349","author":"Iaccarino","year":"2014","journal-title":"J Autoimmun"},{"issue":"362","key":"10.1016\/j.autrev.2014.08.023_bb0015","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"20","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"issue":"344\u20137","key":"10.1016\/j.autrev.2014.08.023_bb0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2014.08.023_bb0025","series-title":"Electrodiagnosis in disease of nerve and muscle: principles and practice","author":"Kimura","year":"1989"},{"key":"10.1016\/j.autrev.2014.08.023_bb0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00004691-199304000-00002","article-title":"The electrodiagnostic examination with myopathies","volume":"10","author":"Wilbourn","year":"1993","journal-title":"J Clin Neurophysiol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.023_bb0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.autrev.2010.09.004","article-title":"Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application","volume":"10","author":"Danieli","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.023_bb0040","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10067-013-2478-x","article-title":"Open-label study on treatment with 20% subcutaneous IgG administration in polymyositis and dermatomyositis","volume":"33","author":"Danieli","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.023_bb0045","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/01.bor.0000434675.70268.bd","article-title":"Editorial: collaborative international research leads to new biomarkers for diagnosis and prediction of outcome in the idiopathic inflammatory myopathy spectrum","volume":"25","author":"Chinoy","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2014.08.023_bb0050","first-page":"2230","article-title":"Polymyositis and dermatomyositis: short term and long-term outcome, and predictive factors of prognosis","volume":"28","author":"Marie","year":"2001","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.023_bb0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/rheumatology\/41.1.22","article-title":"Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality","volume":"41","author":"Sultan","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2014.08.023_bb0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/08916930600622603","article-title":"Survival, mortality and causes of death in inflammatory myopathies","volume":"39","author":"Torres","year":"2006","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.023_bb0065","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/ar3704","article-title":"Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine","volume":"14","author":"Schiopu","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2014.08.023_bb0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.md.0000109755.65914.5e","article-title":"Long term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases","volume":"83","author":"Dank\u00f3","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.023_bb0075","first-page":"188","article-title":"Retrospective analysis of the outcome of patients with idiopathic inflammatory myopathy: a long-term follow-up study","volume":"32","author":"Taborda","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2014.08.023_bb0080","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11926-012-0249-3","article-title":"Morbidity and mortality in adult polymyositis and dermatomyositis","volume":"14","author":"Marie","year":"2012","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.023_bb0085","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00415-014-7313-z","article-title":"Long-term follow-up of 62 patients with myositis","volume":"261","author":"van de Vlekkert","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2014.08.023_bb0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/rheumatology\/kel311","article-title":"The heart in dermatomyositis and polymyositis","volume":"45","author":"Lundberg","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.autrev.2014.08.023_bb0095","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/art.30513","article-title":"Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients","volume":"63","author":"Marie","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.023_bb0100","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/ar4332","article-title":"Functional outcome and prognostic factors in anti-Jo1 patients withanti-synthetase syndrome","volume":"15","author":"Marie","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.023_bb0105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","article-title":"Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients","volume":"73","author":"Aggarwal","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.08.023_bb0110","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s10067-005-1164-z","article-title":"Prognosis and mortality of polymyositis and dermatomyositis patients","volume":"25","author":"Airio","year":"2006","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.023_bb0115","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10067-012-1940-5","article-title":"Intravenous immunoglobulin therapy in adult patients with polymyositis\/dermatomyositis: a systematic literature review","volume":"31","author":"Wang","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"4\u20135","key":"10.1016\/j.autrev.2014.08.023_bb0120","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.autrev.2014.01.026","article-title":"Diagnosis and classification of immune-mediated thrombocytopenia","volume":"13","author":"Lo","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.023_bb0125","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.autrev.2013.01.002","article-title":"A combination therapy protocol of plasmapheresis, intravenous immunoglobulins and betamethasone to treat anti-Ro\/La-related congenital atrioventricular block. A case series and review of the literature","volume":"12","author":"Ruffatti","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.autrev.2014.08.023_bb0130","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.autrev.2013.05.004","article-title":"Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab","volume":"12","author":"Berman","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.023_bb0135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.autrev.2012.04.006","article-title":"Intravenous immunoglobulin for the treatment of Crohn's disease","volume":"12","author":"Rogosnitzky","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.023_bb0140","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2013.02.002","article-title":"Biotherapies in inflammatory ocular disorders: Interferons, immunoglobulins, monoclonal antibodies","volume":"12","author":"Saadoun","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.023_bb0145","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.autrev.2012.10.015","article-title":"Complex regional pain syndrome, prototype of a novel kind of autoimmune disease","volume":"12","author":"Goebel","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"29","key":"10.1016\/j.autrev.2014.08.023_bb0150","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.2174\/138161211798157540","article-title":"Update on intravenous immunoglobulins (IVIg) mechanisms of action and off-label use in autoimmune diseases","volume":"17","author":"Katz","year":"2011","journal-title":"Curr Pharm Des"},{"issue":"11","key":"10.1016\/j.autrev.2014.08.023_bb0155","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.autrev.2012.02.006","article-title":"Intravenous immunoglobulin: exploiting the potential of natural antibodies","volume":"11","author":"Kaveri","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.023_bb0160","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.autrev.2012.08.017","article-title":"Tregitope update: mechanism of action parallels IVIg","volume":"12","author":"Cousens","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.023_bb0165","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.autrev.2013.01.003","article-title":"The future of immunoglobulin therapy: an overview of the 2nd international workshop on natural antibodies in health and disease","volume":"12","author":"Miescher","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.08.023_bb0170","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/978-1-62703-586-6_18","article-title":"Idiotype-specific intravenous immunoglobulin (IVIG) for therapy of autoimmune diseases","volume":"1060","author":"Blank","year":"2014","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.023_bb0175","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.autrev.2012.10.010","article-title":"The protective effect of modified intravenous immunoglobulin in LPS sepsis model is associated with an increased IRA B cells response","volume":"12","author":"Djoumerska-Alexieva","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"3\u20134","key":"10.1016\/j.autrev.2014.08.023_bb0180","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2152\/jmi.54.295","article-title":"Comparison of clinical course of polymyositis and dermatomyositis: a follow-up study in Tokushima University Hospital","volume":"54","author":"Tani","year":"2007","journal-title":"J Med Invest"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.023_bb0185","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.semarthrit.2010.08.003","article-title":"Infectious complications in polymyositis and dermatomyositis: a series of 279 patients","volume":"41","author":"Marie","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.023_bb0190","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/01.bor.0000434664.37880.ac","article-title":"The diagnostic utility of autoantibodies in adult and juvenile myositis","volume":"25","author":"Tansley","year":"2013","journal-title":"Curr Opin Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214001670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214001670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T06:25:31Z","timestamp":1538288731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214001670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1568997214001670"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.08.023","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}